🇺🇸 FDA
Patent

US 10662238

Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use

granted A61KA61K2039/505A61P

Quick answer

US patent 10662238 (Single domain VHH antibodies directed to norovirus GI.1 and GII.4 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/505, A61P, A61P31/12, A61P31/14